This roundtable event will gather gene therapy stakeholders to discuss optimization solutions for patient access to approved gene therapies. Evidera’s Eric Faulkner, MPH, Vice President and Executive Director, Real-World Value and Strategy, Center of Excellence for Precision and Transformative Medicine, will be presenting Considerations for High Risk Pools for Regenerative and Advanced Therapy at the American Society of Gene & Cell Therapy (ASGCT) Value Summit in Washington, DC, September 24, 2018.